develops, manufactures, and markets endovascular stent-grafts that address needs in the repair of aortic aneurysms. Its lead product, Aorfix, an endovascular stent graft which is designed to solve the problems that exist in treating complex tortuous anatomy, which is present in advanced AAA disease.